![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, July 08, 2018 5:36:47 PM
My DD data put together thus far. This is all my personal opinions, results and thoughts on CELZ. Please do your own DD. Please feel free to share this openly or use for yourself to add additional DD or make corrections. Please feel free to share this openly or use for yourself to add additional DD or make corrections.
CELZ
Ticker symbol JLLM was changed to CELZ and effective 5/26/2016
https://www.bloomberg.com/quote/JLLM:US
CELZ has had almost no attention until November/December of 2017 where they are now a Commercial stage company after many years of research and development towards their patents/procedures. Even earlier posts were very limited until around November of 2017.
They have been working on the science of it all for many years, at which point in late 2017 with CaverStem doing so well it is hitting the market and soon with other patents to follow.
according to data I have found in my research they have been in the works since well before 2011 and to me is very great news! They are not a scam in any way as they would not have worked for over 7+ years just to scam people. They have shown that they are a science/results and proof first company proceeding to commercialization when they are sure their patents/procedures are ready, safe and effective and are very picky on their doctors who will offer their patents/procedures as to prevent tarnishing their name/patents/procedures and protecting patients. (This is of course in My own Opinion)
It would seem that Creative Medical Technology Holdings, Inc. had changed JLLM to CELZ in May of 2016 in preparation for commercialization, “a clinical-stage biotechnology company focused on treating erectile dysfunction and stroke using stem cell treatments. Since 2011 Creative Medical Technology Holdings, Inc. (CMTH) and our affiliate company Creative Medical Health, Inc. have focused on regenerative medical solutions for unmet Urological and Neurological needs. Through our own research and collaborations with leading academic institutions, CMT has acquired a groundbreaking stem cell (Amniostem), developed proprietary protocols, built an extensive intellectual property portfolio, developed complete treatment offerings for erectile dysfunction, launched a 40-patient trial for ED at UCLA and are breaking new ground for treating stroke using our newly acquired amniotic fluid-based stem cell. Our team consists of leading international researchers in regenerative medicine. Our “science-first” approach to treatments ensures that all of our treatments are proven to be both safe and effective. “
http://www.creativemedicaltechnology.com/about-us/company/
and now towards the end of 2017 are a commercial stage company.
Last Qtr. Financials
Dec 31-2017
Revenue = 9,600
Cost of revenue = 2,400
Profit = 7,200
Profit margin = %75!! (Great profit margin!)
(expecting significantly higher revenue and profits on the 2nd Qtr. 10-Q)
Other stocks PPS that are similar
Vericel (NASDAQ:VCEL)
Market cap: $392.71 million; current share price: $11.25
Pluristem Therapeutics (NASDAQ:PSTI)
Market cap: $161.84 million; current share price: $1.47
Athersys NASDAQ:ATHX)
Market cap: $226.15 Million; current share price: $1.83
Sangamo Therapeutics (NASDAQ:SGMO)
Market cap: $2.09 billion; current share price: $24.25
BrainstormCell Therapeutics (NASDAQ:BCLI)
Market cap: $64.63 million; current share price: $3.43
Caladrius Biosciences (NASDAQ:CLBS)
Market cap: $54.74 million; current share price: $5.78
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
Doctors and scientific advisory board
Thomas Ichim PhD
http://www.creativemedicaltechnology.com/about-us/board-of-directors/
Amit Patel MS MD
http://www.creativemedicaltechnology.com/about-us/board-of-directors/
Alexander Gershman, M.D.
http://www.caverstem.com/find-a-doctor-2/
Dr. Barton Wachs
http://www.caverstem-oc.com/dr-barton-wachs/
Dr. Sheldon J. Freedman
http://www.caverstem-nv.com/dr-sheldon-j-freedman/
Elias Said, MD,
http://www.caverstem-nm.com/dr-elias-said-and-dr-mark-bieri/
Mark Bieri MD,
http://www.caverstem-nm.com/dr-elias-said-and-dr-mark-bieri/
Eric Duckers MD PhD
http://www.creativemedicaltechnology.com/about-us/scientific-advisory-board/
Timothy Henry MD
http://www.creativemedicaltechnology.com/about-us/scientific-advisory-board/
Warren Sherman MD
http://www.creativemedicaltechnology.com/about-us/scientific-advisory-board/
Masato Mitsuhashi MD PhD
http://www.creativemedicaltechnology.com/about-us/scientific-advisory-board/
Dr. Santosh Kesari
"Dr. Ichim represents a true visionary in the area of cellular therapy, being one of the few people that effectively combines deep knowledge of basic science, regulatory affairs, and clinical translation. I plan to leverage our existing strengths at the Pacific Neurosciences Institute and at St John Providence to accelerate neurological uses of the Company's AmnioStemTM stem cell, particularly in the indication of post-stroke recovery," said Dr. Santosh Kesari, MD, PhD, FANA, FAAN, Scientific Advisory Board Member of CELZ. Dr. Kesari is Chair and Professor, Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, as well as Director of Neuro-oncology, Providence Saint John's Health Center and leads the Pacific Neuroscience Research Center at Pacific Neuroscience Institute.
https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-appoints-internationally-renowned-stem-cell-pioneer-as-chief-scientific-officer-300419991.html
https://www.pacificneuroscienceinstitute.org/people/kesari/
Websites
http://www.creativemedicaltechnology.com/
http://www.caverstem.com/
http://www.caverstem-oc.com/
http://www.caverstem-nv.com/
http://www.caverstem-nm.com/
http://caverstem-nyc.com/
Many more that show via ‘Who Is’ lookup are registered to the same person/place/company that are not yet active.
Patents
You can find most of the Creative Medical Technology Holdings, Inc. here on their website http://www.creativemedicaltechnology.com/intellectual-property/ and can review their US Patents at http://patft.uspto.gov/netahtml/PTO/srchnum.htm by searching their patent number.
1. '9,598,673'
Treatment of disc degenerative disease
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&f=G&l=50&d=PTXT&p=1&S1=(%22Creative+Medical%22.ASNM.)&OS=AN/"Creative+Medical"&RS=AN/"Creative+Medical"
2 '9,375,463'
Compositions and methods for improving sleep using a nutraceutical formulation
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=2&f=G&l=50&d=PTXT&p=1&S1=(%22Creative+Medical%22.ASNM.)&OS=AN/"Creative+Medical"&RS=AN/"Creative+Medical"
3 '9,205,112'
Combination treatment of cardiovascular disease
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=3&f=G&l=50&d=PTXT&p=1&S1=(%22Creative+Medical%22.ASNM.)&OS=AN/"Creative+Medical"&RS=AN/"Creative+Medical"
4 '8,372,797'
Treatment of erectile dysfunction by stem cell therapy
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=4&f=G&l=50&d=PTXT&p=1&S1=(%22Creative+Medical%22.ASNM.)&OS=AN/"Creative+Medical"&RS=AN/"Creative+Medical"
Locations-
Most Google street views do not give justice as they are all from June 2017 or older for all the listed locations. My assumption is that the NV addresses are business locations that are leased.
The phoenix location for Creative Medical Health, LLC has most likely moved from the 2007 to the 2017 W PEORIA AVE location as stated on OTC and CELZ sec filings. The website http://www.creativemedicaltechnology.com/ shows their 2007 address as it has most likely just not been updated. The primary phone number used for all their business locations seems to be the 833.336.7636 as shown on their website.
Creative Medical Technologies Holdings, Inc. (SEC SHOWS 2017 W Peoria Avenue, Phoenix, AZ)
According to:
https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=zybiw1pWZyjaSLMUvtbpoQ%253d%253d&nt7=0
Address: 3870 E FLAMINGO RD STE 156 , LAS VEGAS, NV 89121
This is the address listed by the NVSOS.GOV business entity information filled on 12/3/1998
CREATIVE MEDICAL TECHNOLOGIES, INC.
According to:
https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=YFRW2fC%252b4Qa8TBDsdI6rQQ%253d%253d&nt7=0
Address: 701 S Carson ST STE 200 Carson City, NV 89701
This is the address listed by the NVSOS.GOV business entity information filled on 12/30/2015
CAVERSTEM INTERNATIONAL LLC
According to:
https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=1tcgzWSJDy63jiuzT1MACw%253d%253d&nt7=0
Address: 701 S Carson ST STE 200 Carson City, NV 89701
This is the address listed by the NVSOS.GOV business entity information filled on 6/8/2018
Creative Medical Health, LLC
According to:
https://ecorp.azcc.gov/BusinessSearch/BusinessInfo?entityNumber=L15369569
Address: 2007 W PEORIA AVE , PHOENIX, AZ 85029, USA
This is the address listed by the ecorp.azcc.gov business entity information filled on 7/6/2009
Recent CELZ News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM